Meeting NewsVideo

VIDEO: Novel treatments show efficacy for fatty liver, cirrhosis

December 5, 2019
BOSTON — In this exclusive video from The Liver Meeting 2019, Manu Chakravarthy, MD, PhD, chief medical officer and senior vice president of…

Thyroid hormone receptor progresses to phase 2b for NASH

November 27, 2019
Viking Therapeutics announced the initiation of a phase 2b trial of VK2809, a novel liver-selective thyroid hormone receptor beta agonist undergoing…

Meeting News

Improving frailty in patients with cirrhosis listed for LT reduces mortality

November 15, 2019
BOSTON — Improvements in frailty among patients with cirrhosis awaiting liver transplantation lowered the risk for mortality regardless of…

Meeting NewsVideo

Terlipressin demonstrates ‘major advance’ in hepatorenal syndrome treatment

November 12, 2019
BOSTON — In this exclusive video from The Liver Meeting 2019, Arun Sanyal, MD, professor of medicine at Virginia Commonwealth University…

Meeting NewsVideo

VIDEO: Novel therapy safe, effective in acute, severe alcoholic hepatitis

November 12, 2019
BOSTON — In this exclusive video from The Liver Meeting 2019, Tarek Hassanein, MD, FAASLD, professor of medicine at UC San Diego Health and…

Meeting News

Hepatic encephalopathy tool detects minimal impairment in the elderly

November 11, 2019
BOSTON — In a multicenter study of older patients with cirrhosis, the EncephalApp tool accurately diagnosed cognitive impairment and hepatic…

Meeting News

Cirrhosis-related financial burden impairs liver cancer surveillance

November 10, 2019
BOSTON — Researchers found that health care financial burden was common in patients with cirrhosis and may be associated with lower receipt of…

Meeting News

Low risk for adverse cirrhosis events in pregnant women ‘reassuring’

November 10, 2019
BOSTON — In pregnant women with cirrhosis, less than 2% had liver decompensation within 1 year after delivery and the odds for decompensation…

In the Journals

Albumin, liver stiffness after DAA therapy for HCV stratify liver cancer risk

November 8, 2019
Albumin levels and liver stiffness measurements taken during direct-acting antiviral therapy follow-up can stratify liver cancer risk among patients…

In the Journals

‘Downgrading’ acute-on-chronic liver failure improves post-LT survival

November 6, 2019
Improving acute-on-chronic liver failure grade from time of liver transplant listing to time of transplant enhanced posttransplant survival…

Cirrhosis update: 6 latest reports on improving prevention, management

November 2, 2019
Cirrhosis, also known as stage 4 fibrosis, is a late stage of scarring in the liver that can result from many chronic liver diseases. Currently…

Meeting NewsVideo

VIDEO: New treatments available for coagulation disorders in cirrhosis

October 31, 2019
SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Robert S. Brown, MD, from the Weill Cornell Medical Center…

Meeting NewsVideo

VIDEO: National Liver Conference covers new, underused therapies for liver disease

October 31, 2019
SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Stephen A. Harrison, MD, medical director of Pinnacle Clinical…

Meeting NewsVideo

VIDEO: Cirrhosis best practice requires ‘taking ownership’ of patient

October 26, 2019
SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Bruce Runyon, MD, from the Loma Linda University Medical Center…

Palliative care would benefit patients with cirrhosis

October 26, 2019
SAN ANTONIO – Though 72% of patients with cirrhosis report poor quality of life, only a third receive referral to palliative care, according to…

Meeting News

Physical exams, seemingly forgotten, can help diagnose cirrhosis

October 26, 2019
SAN ANTONIO – Despite the best medical training in the world, new trainees in hepatology often lack the primary training in giving a full…

Meeting News

National Liver Conference to cover ‘tsunami’ of new data on liver disease

October 24, 2019
SAN ANTONIO — The National Liver Congress will convene October 25th, providing a broad scientific program and exhibit of products and services…

Cover Story

Cirrhosis Fueled by Environmental Factors, Mental Health Disorders

Healio Gastroenterology, October 2019
Liver cirrhosis, also known as the fourth and most advanced stage of fibrosis, can result from a variety of causes including nonalcoholic fatty liver…

Meeting News

NASPGHAN 2019 chronic liver disease symposium provides update for GIs

October 16, 2019
CHICAGO — During this year’s North American Society for Pediatric Gastroenterology, Hepatology & Nutrition annual meeting, Mercedes

Alcoholic hepatitis drug candidate shows ‘life-saving potential’

September 20, 2019
Data from a phase 2a clinical trial of DUR-928, an endogenous, small-molecule new chemical entity, for patients with alcoholic hepatitis demonstrated…